Ocrelizumab is noninferior to fingolimod, demonstrating efficacy and safety in children and adolescents with ...

A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate deficiency.

Leber hereditary optic neuropathy (LHON) is a genetic mitochondrial disorder that damages retinal ganglion cells, resulting in rapid vision loss. Idebenone is expected to restore mitochondrial ...

Shunt surgery significantly improves gait velocity at three months among patients with idiopathic normal-pressure hydrocephalus with a response to temporary CSF drainage.

Estrogen therapy may reduce Alzheimer disease risk, with lower risk seen in association with early initiation.

The FDA has extended the review period of the New Drug Application for tolebrutinib for the treatment of non-relapsing, secondary progressive MS and to slow disability accumulation independent of ...

Cocoa extract supplementation yields a reduction in high-sensitivity C-reactive protein and an increase in interferon-γ.

After menopause, women with MS show accelerated loss of volume in brain structures associated with memory, attention, and problem-solving.

Daily treatment with atogepant maintains long-term safety, efficacy, and functional benefits over 1 year in patients with chronic and episodic migraine.

Dementia risk in type 2 diabetes varies by treatment, with some metformin-based combination therapies offering greater protection.

Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...

A machine learning–based tool accurately predicted risk for recurrent inflammatory activity after DMT discontinuation in MS, highlighting its potential to guide personalized treatment decisions.